GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 322 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $60,900,000 | -80.9% | 280,774 | -89.8% | 0.01% | -82.0% |
Q4 2020 | $318,187,000 | +18.7% | 2,757,013 | +0.1% | 0.06% | +3.4% |
Q3 2020 | $268,165,000 | +17.2% | 2,754,644 | +47.7% | 0.06% | +7.3% |
Q2 2020 | $228,894,000 | +129.3% | 1,865,171 | +63.6% | 0.06% | +89.7% |
Q1 2020 | $99,827,000 | -13.6% | 1,139,964 | +3.2% | 0.03% | +11.5% |
Q4 2019 | $115,497,000 | +6.2% | 1,104,605 | +16.9% | 0.03% | 0.0% |
Q3 2019 | $108,717,000 | -76.7% | 945,114 | -65.2% | 0.03% | -76.4% |
Q2 2019 | $467,552,000 | +2.3% | 2,712,176 | +0.0% | 0.11% | -0.9% |
Q1 2019 | $457,090,000 | +73.1% | 2,711,574 | +0.0% | 0.11% | +54.2% |
Q4 2018 | $264,080,000 | -39.3% | 2,711,572 | +7.7% | 0.07% | -32.1% |
Q3 2018 | $434,802,000 | +42.9% | 2,517,090 | +15.4% | 0.11% | +63.1% |
Q2 2018 | $304,372,000 | +23.8% | 2,181,250 | 0.0% | 0.06% | +18.2% |
Q1 2018 | $245,761,000 | +29.7% | 2,181,250 | +51.9% | 0.06% | +34.1% |
Q4 2017 | $189,550,000 | +176.4% | 1,435,879 | +112.5% | 0.04% | +156.2% |
Q3 2017 | $68,587,000 | +1.2% | 675,800 | 0.0% | 0.02% | 0.0% |
Q2 2017 | $67,749,000 | -11.9% | 675,800 | +6.3% | 0.02% | -11.1% |
Q1 2017 | $76,894,000 | +8.2% | 635,800 | 0.0% | 0.02% | 0.0% |
Q4 2016 | $71,051,000 | -29.6% | 635,800 | -16.4% | 0.02% | -30.8% |
Q3 2016 | $100,981,000 | +152.3% | 760,800 | +74.1% | 0.03% | +136.4% |
Q2 2016 | $40,025,000 | +26.9% | 437,100 | 0.0% | 0.01% | +22.2% |
Q1 2016 | $31,537,000 | +3.9% | 437,100 | 0.0% | 0.01% | +12.5% |
Q4 2015 | $30,352,000 | -24.0% | 437,100 | 0.0% | 0.01% | -33.3% |
Q3 2015 | $39,938,000 | -25.6% | 437,100 | 0.0% | 0.01% | -20.0% |
Q2 2015 | $53,693,000 | +68.3% | 437,100 | +24.9% | 0.02% | +66.7% |
Q1 2015 | $31,905,000 | +124.5% | 350,100 | +66.7% | 0.01% | +125.0% |
Q4 2014 | $14,213,000 | – | 210,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |